CD274 and nonpapillary renal cell carcinoma: Previously studies revealed that traditional biomarkers of immunotherapy such as PD-L1 and TMB didn’t show the ability to distinguish the clinical outcome in ccRCC and the microenvironment of CD8+ T-cell infiltration was related to poor prognosis of immunotherapy.